Amgen Crypto Price Prediction, Value and Chart (AMG) $0.5192 (As of 07/18/2025 04:32 PM ET) Add Share Share 1-Hour Change +0.0133% 24-Hour Change +0.0133% 7-Day ChangeN/A 1-Day Volume$89.84 Market Cap$0.00 BTC Price0.00001767 BTC Circulating Supply99.00 million Total Supply99.00 million Maximum Supply74.00 million Currency ProfileHeadlinesAdvanced ChartSocial Media 30 days | 90 days | 180 days | Advanced Chart Receive AMG News and Prices via Email Sign-up to receive the latest news and price data for Amgen and its competitors with MarketBeat's CryptoBeat newsletter. Email Address About Amgen (AMG) Amgen (AMG) is a cryptocurrency launched in 2022and operates on the BNB Smart Chain (BEP20) platform. Amgen has a current supply of 99,000,000 with 0 in circulation. The last known price of Amgen is 0.51921206 USD and is up 0.00 over the last 24 hours. It is currently trading on 3 active market(s) with $0.00 traded over the last 24 hours. More information can be found at https://theamgen.com/. Read More Amgen NewsHSBC Trims Amgen (AMGN) Price Target, Maintains Buy Ratinginsidermonkey.com - July 18 at 3:21 PMAmgen’s Phase 3 Study on Etelcalcetide: A Potential Game-Changer for Pediatric Kidney Diseasetipranks.com - July 18 at 12:57 PMAmgen’s Phase 3 Study on Maridebart Cafraglutide: A Potential Game-Changer in Weight Managementtipranks.com - July 18 at 12:08 PMAmgen’s ABP 234 vs. Keytruda®: A New Frontier in Lung Cancer Treatment?tipranks.com - July 18 at 12:08 PMAmgen’s Tarlatamab Study: A New Hope in Small Cell Lung Cancer?tipranks.com - July 18 at 12:08 PMAmgen’s New Obesity Drug: A Potential Game-Changer?tipranks.com - July 18 at 12:08 PMAmgen’s Promising Melanoma Study: A Potential Game-Changer?tipranks.com - July 18 at 12:08 PMAmgen’s New Study on ABP 692 vs. Ocrelizumab: A Potential Game Changer in MS Treatmenttipranks.com - July 18 at 12:08 PMAmgen’s Phase 3 Study on Etelcalcetide: A Potential Game-Changer for Pediatric Kidney Patientstipranks.com - July 16 at 12:16 PMGenelux Corporation Appoints Eric Groen as General Counsel and Head of Business Developmentquiverquant.com - July 7 at 7:24 AMAmgen’s Rocatinlimab Study: A Potential Game-Changer in Atopic Dermatitis Treatmenttipranks.com - July 3 at 12:20 PMAmgen’s Tarlatamab Study: A Potential Game-Changer in Small Cell Lung Cancer Treatmenttipranks.com - July 3 at 12:20 PMAmgen’s Innovative Approach: Self-Administered Rocatinlimab for Atopic Dermatitistipranks.com - July 3 at 12:20 PMAmgen’s Rocatinlimab Study: A Potential Game-Changer for Atopic Dermatitistipranks.com - July 3 at 12:20 PMAmgen (AMGN) Announces Full Results from Part 1 of the Phase 2 study of MariTideinsidermonkey.com - July 3 at 4:06 AMAmgen stock gains as William Blair reiterates Outperform on positive cancer trialinvesting.com - June 30 at 11:48 AMAmgen’s Tarlatamab Study: A Potential Game-Changer in Lung Cancer Treatmenttipranks.com - June 27 at 12:09 PMDividend Stock Analysis: Amgen, Inc. talkmarkets.com - June 27 at 11:33 AMCan Amgen Advance On Anti-Obesity Drugs?talkmarkets.com - June 25 at 5:15 AMOpenAI Is Poaching Microsoft’s Customers and Triggering an AI Turf Wartipranks.com - June 24 at 10:56 AMSell Rating for Amgen Amid Concerns Over MariTide Trials and Market Positioningtipranks.com - June 24 at 6:00 AMAmgen’s Stock Faces Pressure Amid Safety Concerns with MariTide: Hold Rating Maintainedtipranks.com - June 24 at 6:00 AMAmgen (AMGN) Stock Falls After Mixed MariTide Trial Updatebenzinga.com - June 23 at 4:49 PMAmgen Inc (AMGN) Announces Promising Results from Phase 2 Study of MariTide for Obesity ...gurufocus.com - June 23 at 3:46 PMAmgen (AMGN) Shares Fall After Phase 2 MariTide Study Results | AMGN Stock Newsgurufocus.com - June 23 at 3:46 PMAmgen (AMGN) Showcases Promising Results for MariTide in Phase 2 Study | AMGN Stock Newsgurufocus.com - June 23 at 2:56 PMDemocrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plancnbc.com - June 17 at 10:41 AMDemocrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plancnbc.com - June 17 at 10:41 AMAmgen’s Strong Cash Flow Supports Reliable Dividend Paymentsinsidermonkey.com - June 17 at 12:19 AMAmgen SVP Rachna Khosla sells $434,520 in stockinvesting.com - June 6 at 8:56 PMAmgen Inc. (AMGN)’s Nplate Effective for GI Cancer Thrombocytopaeniainsidermonkey.com - June 3 at 1:33 AMAmgen (AMGN) Reports Positive Results from Phase 3 DeLLphi-304 Trial | AMGN Stock Newsgurufocus.com - June 2 at 8:35 AMSanofi to Acquire Vigil Neuroscience for Up to $10.00 per Share in Cash; Transaction Expected to Enhance Alzheimer’s Drug Developmentquiverquant.com - May 21 at 7:48 PMAMGEN TO PRESENT AT THE 2025 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE | AMGN Stock Newsgurufocus.com - May 16 at 4:20 PMAmgen (AMGN) Price Target Adjusted to $328 by Piper Sandler | AMGN Stock Newsgurufocus.com - May 16 at 1:29 PMRegeneron wins over $400M jury award as Amgen found liable in antitrust caseseekingalpha.com - May 16 at 8:16 AMAmgen owes $406 million for monopolizing cholesterol drug market, US jury saysinvesting.com - May 15 at 5:02 PMStock Of The Day: Amgen Slips With Healthcare Sector, But Signals Point To A Reversalbenzinga.com - May 15 at 4:25 PMIs Amgen Inc. (AMGN) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?finance.yahoo.com - May 15 at 4:45 AMCautious Hold on Amgen: Navigating Competitive Challenges and Market Potential for MariTidetipranks.com - May 14 at 9:45 PMAmgen Inc (AMGN) Shares Up 3.46% on May 12gurufocus.com - May 12 at 1:20 PMAmgen Inc. (AMGN): A Bull Case Theoryinsidermonkey.com - May 7 at 4:21 PMIs Amgen Inc. (AMGN) the Best Dow Stock?insidermonkey.com - May 7 at 3:11 PMAnalyst Update: Amgen (AMGN) Price Target Raised to $280 by Mizuho | AMGN Stock Newsgurufocus.com - May 7 at 9:48 AMAmgen’s Mixed Financial Outlook: Strong Q1 Performance but Cautious Future Guidance Leads to Hold Ratingtipranks.com - May 5 at 5:30 AMAmgen (AMGN) Receives a Revised Price Target from UBS Analyst | AMGN Stock Newsgurufocus.com - May 2 at 7:39 PMAmgen (AMGN): RBC Capital Maintains Rating, Lowers Price Target | AMGN Stock Newsgurufocus.com - May 2 at 3:59 PMAmgen Inc. (NASDAQ:AMGN) Q1 2025 Earnings Call Transcriptinsidermonkey.com - May 2 at 8:56 AMAmgen Inc (AMGN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Pricing Challengesgurufocus.com - May 2 at 2:45 AMQ1 2025 Amgen Inc Earnings Call Transcriptgurufocus.com - May 2 at 1:04 AMSee All Recent Headlines Amgen Currency Details Name Amgen SymbolAMG Market Capitalization$0.00 Coin or TokenToken Algorithm Proof Type Genesis Date3/14/2022 Mineable?No Official Links Official Websitetheamgen.com Official Website (Alt)N/A BitcoinTalk AnnouncementN/A Twitter Account@theamgen Facebook PageView Github AccountViewCommunity Discussion Reddit CommunityN/A Telegram GroupView Discord GroupN/A Message BoardN/A Message Board (Alt)N/AResearch Tools Blockchain Explorerbscscan.com Blockchain Explorer (Alt)polygonscan.com CoinMarketCapView CryptoCompareN/A CoinGeckoView About Amgen (AMG) Amgen (AMG) Frequently Asked Questions How do I buy Amgen? It is not possible to buy all cryptocurrencies with U.S. dollars. Bitcoin, Bitcoin Cash, Ethereum, Litecoin and other popular cryptocurrencies can be purchased with U.S. dollars using Coinbase. Once you have purchased Bitcoin using Coinbase, you can then transfer your Bitcoin to an exchange such as Binance to purchase other cryptocurrencies, including Amgen. Where can I get Amgen wallet? Amgen produces its own wallet software that is available for download on its website, which allows you to store Amgen on your computer. For maximum security, you can store your cryptocurrencies on a dedicated hardware wallet such as a TREZOR wallet or a Ledger Nano X. If you do not wish to buy a hardware wallet, you may consider using a mobile wallet such as Atomic Wallet, Jaxx, or Coinomi to store multiple cryptocurrencies with some added security benefits. What is the value of Amgen? One Amgen (AMG) is currently worth $0.52 on major cryptocurrency exchanges. You can also exchange one Amgen for 0.00001767 bitcoin(s) on major exchanges. The value (or market capitalization) of all available Amgen in U.S. dollars is $0.00. Amgen (AMG) Price Chart for Friday, July, 18, 2025 Amgen (AMG) Twitter Feed Tweets by @theamgenLoading… This page was last updated on 7/18/2025 by MarketBeat.com Staff Adding Amgen Please log in to your account or sign up in order to add this asset to your watchlist. Adding Choose a watchlist: Watchlist Adding You have already added ten holdings to your watchlist. Upgrade to MarketBeat All Access to add more holdings to your watchlist. Share Amgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
